Characterization of the Association of Tissue Factor Pathway Inhibitor With Human Placenta

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000042456.84190.f0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Tissue Factor Pathway Inhibitor

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2016English

Protein S Stimulates Inhibition of the Tissue Factor Pathway by Tissue Factor Pathway Inhibitor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Tissue Factor Pathway Inhibitor Revisited

Journal of Thrombosis and Haemostasis
MedicineHematology
2004English

Tissue Factor Pathway Inhibitor Deficient Mice

Japanese Journal of Thrombosis and Hemostasis
1998English

Evaluation of Plasma Levels of Tissue Factor and Tissue Factor Pathway Inhibitor in Patients With Psoriasis

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2019English

Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

Comparison of the Inhibitory Activities of Human Tissue Factor Pathway Inhibitor (TFPI)α and TFPIβ

Journal of Thrombosis and Haemostasis
MedicineHematology
2013English

Tissue Factor Pathway Inhibitor and Bacterial Infection

Journal of Thrombosis and Haemostasis
MedicineHematology
2011English

Tissue Factor Pathway Inhibitor for Prediction of Placenta-Mediated Adverse Pregnancy Outcomes in High-Risk Women: AngioPred Study

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy